Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).

Saved in:
Bibliographic Details
Title: Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).
Authors: Ng RA; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Barratt S; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Parisian A; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Palanisamy GS; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Phukan S; Aragen Life Sciences Private Ltd., Hyderabad 500076, India., Sun R; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Robello B; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Peña G; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Sapugay J; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Yeghikyan D; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Wang C; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Satish Kher S; Aragen Life Sciences Private Ltd., Hyderabad 500076, India., Thangathirupathy S; Aragen Life Sciences Private Ltd., Hyderabad 500076, India., Millikin R; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Yu G; Synterys, Inc., Union City 94587, California, United States., Watanabe T; Adesis, Inc., New Castle 19720, Delaware, United States., Zhou F; Adesis, Inc., New Castle 19720, Delaware, United States., Rich B; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Duncan A; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Andersen SE; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Chawla R; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Zak DR; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood 60153, Illinois, United States., Heerding DA; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Hearn BR; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Greene G; The Ben May Department for Cancer Research, University of Chicago, Chicago 60637, Illinois, United States., Harmon CL; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Hodges-Gallagher L; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Kushner PJ; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States., Fanning SW; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood 60153, Illinois, United States., Myles DC; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.
Source: ACS omega [ACS Omega] 2025 May 29; Vol. 10 (22), pp. 22685-22700. Date of Electronic Publication: 2025 May 29 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101691658 Publication Model: eCollection Cited Medium: Internet ISSN: 2470-1343 (Electronic) Linking ISSN: 24701343 NLM ISO Abbreviation: ACS Omega Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40521471
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ng+RA%22">Ng RA</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Barratt+S%22">Barratt S</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Parisian+A%22">Parisian A</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Palanisamy+GS%22">Palanisamy GS</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Phukan+S%22">Phukan S</searchLink>; Aragen Life Sciences Private Ltd., Hyderabad 500076, India.<br /><searchLink fieldCode="AU" term="%22Sun+R%22">Sun R</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Robello+B%22">Robello B</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Peña+G%22">Peña G</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Sapugay+J%22">Sapugay J</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Yeghikyan+D%22">Yeghikyan D</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Satish+Kher+S%22">Satish Kher S</searchLink>; Aragen Life Sciences Private Ltd., Hyderabad 500076, India.<br /><searchLink fieldCode="AU" term="%22Thangathirupathy+S%22">Thangathirupathy S</searchLink>; Aragen Life Sciences Private Ltd., Hyderabad 500076, India.<br /><searchLink fieldCode="AU" term="%22Millikin+R%22">Millikin R</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Yu+G%22">Yu G</searchLink>; Synterys, Inc., Union City 94587, California, United States.<br /><searchLink fieldCode="AU" term="%22Watanabe+T%22">Watanabe T</searchLink>; Adesis, Inc., New Castle 19720, Delaware, United States.<br /><searchLink fieldCode="AU" term="%22Zhou+F%22">Zhou F</searchLink>; Adesis, Inc., New Castle 19720, Delaware, United States.<br /><searchLink fieldCode="AU" term="%22Rich+B%22">Rich B</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Duncan+A%22">Duncan A</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Andersen+SE%22">Andersen SE</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Chawla+R%22">Chawla R</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Zak+DR%22">Zak DR</searchLink>; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood 60153, Illinois, United States.<br /><searchLink fieldCode="AU" term="%22Heerding+DA%22">Heerding DA</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Hearn+BR%22">Hearn BR</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Greene+G%22">Greene G</searchLink>; The Ben May Department for Cancer Research, University of Chicago, Chicago 60637, Illinois, United States.<br /><searchLink fieldCode="AU" term="%22Harmon+CL%22">Harmon CL</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Hodges-Gallagher+L%22">Hodges-Gallagher L</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Kushner+PJ%22">Kushner PJ</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.<br /><searchLink fieldCode="AU" term="%22Fanning+SW%22">Fanning SW</searchLink>; Department of Cancer Biology, Loyola University Chicago Stritch School of Medicine, Maywood 60153, Illinois, United States.<br /><searchLink fieldCode="AU" term="%22Myles+DC%22">Myles DC</searchLink>; Olema Oncology, 780 Brannan Street, San Francisco 94107, California, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101691658%22">ACS omega</searchLink> [ACS Omega] 2025 May 29; Vol. 10 (22), pp. 22685-22700. <i>Date of Electronic Publication: </i>2025 May 29 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101691658 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2470-1343 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224701343%22">24701343 </searchLink><i>NLM ISO Abbreviation: </i>ACS Omega <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40521471
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1021/acsomega.4c11023
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 22685
    Titles:
      – TitleFull: Discovery of Palazestrant (OP-1250), a Potent and Orally Bioavailable Complete Estrogen Receptor Antagonist (CERAN) and Selective Estrogen Receptor Degrader (SERD).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ng RA
      – PersonEntity:
          Name:
            NameFull: Barratt S
      – PersonEntity:
          Name:
            NameFull: Parisian A
      – PersonEntity:
          Name:
            NameFull: Palanisamy GS
      – PersonEntity:
          Name:
            NameFull: Phukan S
      – PersonEntity:
          Name:
            NameFull: Sun R
      – PersonEntity:
          Name:
            NameFull: Robello B
      – PersonEntity:
          Name:
            NameFull: Peña G
      – PersonEntity:
          Name:
            NameFull: Sapugay J
      – PersonEntity:
          Name:
            NameFull: Yeghikyan D
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Satish Kher S
      – PersonEntity:
          Name:
            NameFull: Thangathirupathy S
      – PersonEntity:
          Name:
            NameFull: Millikin R
      – PersonEntity:
          Name:
            NameFull: Yu G
      – PersonEntity:
          Name:
            NameFull: Watanabe T
      – PersonEntity:
          Name:
            NameFull: Zhou F
      – PersonEntity:
          Name:
            NameFull: Rich B
      – PersonEntity:
          Name:
            NameFull: Duncan A
      – PersonEntity:
          Name:
            NameFull: Andersen SE
      – PersonEntity:
          Name:
            NameFull: Chawla R
      – PersonEntity:
          Name:
            NameFull: Zak DR
      – PersonEntity:
          Name:
            NameFull: Heerding DA
      – PersonEntity:
          Name:
            NameFull: Hearn BR
      – PersonEntity:
          Name:
            NameFull: Greene G
      – PersonEntity:
          Name:
            NameFull: Harmon CL
      – PersonEntity:
          Name:
            NameFull: Hodges-Gallagher L
      – PersonEntity:
          Name:
            NameFull: Kushner PJ
      – PersonEntity:
          Name:
            NameFull: Fanning SW
      – PersonEntity:
          Name:
            NameFull: Myles DC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 05
              Text: 2025 May 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2470-1343
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 22
          Titles:
            – TitleFull: ACS omega
              Type: main
ResultId 1